Recursion CEO has shares withheld for taxes
RECURSION PHARMACEUTICALS, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
RECURSION PHARMACEUTICALS, INC. CEO and President Najat Khan reported a routine tax-related share disposition. On this Form 4, 62,701 shares of Class A Common Stock were withheld at $3.04 per share to satisfy tax withholding and remittance obligations tied to the net settlement of restricted stock units, rather than being sold on the open market. Following this withholding, Khan directly holds 2,199,384 shares of Class A Common Stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A Common Stock | 62,701 | $3.04 | $191K |
Footnotes (1)
- F1. Represents shares that have been withheld by the Issuer to satisfy its tax withholding and remittance obligations in connection with the net settlement of restricted stock units.
Key Figures
Key Terms
restricted stock units financial
net settlement financial
tax withholding and remittance obligations financial
Class A Common Stock financial
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RXRX CEO Najat Khan report on this Form 4?
What does the F transaction code mean in this RXRX Form 4?
What role did restricted stock units play in this RXRX insider transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.